16:58 EDT Aspire Biopharma (ASBP) files to sell 147.18M shares of common stock for holders
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASBP:
- Aspire Biopharma engages athletes, influencers for BUZZ BOMB awareness
- Aspire Biopharma announces initial production order of 2M servings of BUZZ BOMB
- Aspire Biopharma announces results from trial of sublingual aspirin product
- Aspire Biopharma Secures $9.7M Through Securities Agreement
- Aspire Biopharma launches BUZZ BOMB at FitCon, FitExpo